About
Launched in March 2025, The MASLD Action Network brings together a multidisciplinary group of experts committed to making Metabolic dysfunction-associated steatotic liver disease (MASLD) a national public health priority in Australia. We share knowledge, generate resources and collaborate on projects that will raise the national profile of MASLD for better quality of life and health system experiences of affected Australians.
This network provides a forum for:
- Exploration of issues and collaborative problem solving
- Sharing information and co-developing resources
- Elevating the voice of lived experience
- Collaborative policy change advocacy and fundraising
We’re currently welcoming new members with a view to expand this network and deepen our work together. If you are interested in being involved, we’d love to hear from you. Click here to find out how you can connect with the network.
MASLD Action Network Charter
The MASLD Action Network Charter outlines our shared purpose, values, and how we’ll work together to drive national action. Click the button below to read the charter in full.
Meeting Schedule
All regular MASLD Action Network online meetings will be organised and facilitated by LiverWELL via Teams on the following dates:
Wednesday, 4th June 2025: 12:00pm – 1:30pm
Tuesday, 5th August 2025: 10:00am – 11:30am
Wednesday, 8th October 2025: 3:00pm – 4:30pm
Wednesday, 3rd December 2025: 12:30pm – 2:00pm
Tuesday, 3rd February 2026: 9:00am – 10:30am
Wednesday, 8th April 2026: 2:00pm – 3:30pm
LiverWELL will provide details of meetings to confirmed participants via email.
How to Get Involved
Please refer to the network charter for a description of the below participation tiers.
Peripheral participant involvement:
Please register by emailing LiverWELL at liverhealth@liverwell.org.au to subscribe to the network email list.
Core member participation:
To submit your expression of interest, please click on the button below and complete the online form. We will be in touch with you once we review your submission.